Immunology of inflammatory bowel disease

Current Opinion in Gastroenterology

Volumn 12, Issue 4, 1996, Pages 340-344

  McCabe, Robert P ^a   Dean, Philip ^a   Elson, Charles O ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ANTIBODY; CYTOKINE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

B LYMPHOCYTE; ENTERITIS; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNOLOGY; INFLAMMATION; INTESTINE FLORA; INTESTINE MUCOSA; MACROPHAGE; REVIEW; T LYMPHOCYTE;

EID: 0029835747     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-199607000-00005     Document Type: Review

References (34)

1. Grimm MC, Pavli P, Van de Pol E, Doe WF: Evidence for a CD14+ population of monocytes in inflammatory bowel disease mucosa: implications for pathogenesis. Clin Exp Immunol 1995, 100:291-297. Mononuclear cells expressing the receptor for bacterial lipopolysaccharide CD14, normally absent in the lamina propria, are present in the lamina propria of IBD intestine.
2. Targan SR, Deem RL, Liu M, Wang S, Nel A: Definition of a lamina propria T cell responsive state: enhanced cytokine responsiveness of T cells stimulated through the CD2 pathway. J Immunol 1995, 154:664-675. A possible mechanism for the generation of the lamina propria T-cell phenotype is investigated.
3. Burgio VL, Fais S, Boirivant M, Perrone A, Pallone F: Peripheral monocyte and naive T-cell recruitment and activation in Crohn's disease. Gastroenterology 1995, 109:1029-1038. The mechanisms by which leukocytes migrate into inflamed intestinal tissue are characterized.
4. Bargatze RF, Jutila MA, Butcher EC: Distinct roles of L-selectin and inte grins a4b7 and LFA-1 in lymphocyte homing to Peyer's patch-HEV in situ: the multistep model confirmed and refined. Immunity 1995, 3:99-108. Adhesion molecules important in gut-specific leukocyte trafficking are described.
5. Powrie F: T cells in inflammatory bowel disease: protective and pathogenic roles. Immunity 1995, 3:171-174. An excellent review of how T-cell dysregulation may lead to pathologic gastrointestinal inflammation.
6. Niessner M, Volk BA: Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 1995, 101:428-435.
7. Kucharzik T, Stoll R, Lugering N, Domschke W: Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBO). Clin Exp Immunol 1995, 100:452-456.
8. Kusugami K, Haruta J, Ieda M, Shinoda M, Ando T, Kuroiwa A, Ina K, lokawa H, Ishihara A, Sarai S, et al.: Phenotypic and functional characterization of T-cell lines generated from colonoscopic biopsy specimens in patients with ulcerative colitis. Dig Dis Sci 1995, 40:198-210.
9. Schreiber S, Heinig T, Thiele HG, Raedler A: Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology 1995, 108:1434-1444. The anti-inflammatory role of interleukin-10 on immune cells from patients with IBD is demonstrated, as is the effectiveness of interleukin-10 delivered in vivo as an enema.
10. Schreiber S, Heinig T, Panzer U, Reinking R, Bouchard A, Stahl PD, Raedler A: Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease. Gastroenterology 1995, 108:21-33. Lack of responsiveness to an anti-inflammatory cytokine by cells from patients with IBD is demonstrated.
11. Baca-Estrada ME, Wong DK, Croitoru K: Cytotoxic activity of V beta 8+ T cells in Crohn's disease: the role of bacterial superantigens. Clin Exp Immunol 1995, 99:398-403.
12. Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K, Zumbuschenfelde KHM: Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 1995, 102:448-455. Patients with IBD may have a disturbance in the mechanisms that result in immune unresponsiveness of the normal bacterial flora.
13. Yacyshyn BR, Pilarski LM: Expression of CD45RO on circulating CD19+ B-cells in Crohn's disease. Gut 1993, 34:1698-1704.
14. Yacyshyn BR, Meddings JB: CD45RO expression on circulating CD19+B cells in Crohn's disease correlates with intestinal permeability. Gastroenterology 1995, 108:132-137. Circulating B cells from Crohn's disease patients, but not control subjects, exhibit a surface molecule representing previous activation by antigen.
15. Reumaux D, Meziere C, Colombel JF, Duthilleul P, Muller S: Distinct production of autoantibodies to nuclear components in ulcerative colitis and in Crohn's disease. Clin Immunol Immunopathol 1995, 77:349-357.
16. Targan SR, Landers C, Vidrich A, Czaja AJ. High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis. Gastroenterology 1995, 108:1159-1166.
17. Vidrich A, Lee J, James E, Cobb L, Targan S: Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis. J Clin Immunol 1995, 15:293-299. Potential targets of pANCAs differ depending on the associated disease.
18. Targan SR, Landers CJ, Cobb L, MacDermott RP, Vidrich A: Perinuclear anti-neutrophil cytoplasmic antibodies are spontaneously produced by mucosal B cells of ulcerative colitis patients. J Immunol 1995, 155:3262-3267. Ulcerative colitis-associated pANCAs are produced by lamina propria B cells.
19. Duerr RH, Neigut DA: Molecularly defined HLA-DR2 alleles in ulcerative colitis and an antineutrophil cytoplasmic antibody-positive subgroup. Gastroenterology 1995, 108:423-427.
20. Lee JC, Lennard-Jones JE, Cambridge G: Antineutrophil antibodies in familial inflammatory bowel disease. Gastroenterology 1995, 108:428-433.
21. Yang P, Jarnerot G, Danielsson D, Tysk C, Lindberg E: P-ANCA in monozygotic twins with inflammatory bowel disease. Gut 1995, 36:887-890.
22. Sandborn WJ, Landers CJ, Tremaine WJ, Targan SR: Antineutrophil cytoplasmic antibody correlates with chronic pouchitis after ileal pouch-anal anastomosis. Am J Gastroenterol 1995, 90:740-747.
23. Biancone L, Mandal A, Yang H, Dasgupta T, Paoluzi AO, Marcheggiano A, Paoluzi P, Pallone F, Das KM: Production of immunoglobulin G and G1 antibodies to cytoskeletal protein by lamina propria cells in ulcerative colitis. Gastroenterology 1995, 109:3-12. IgG antibodies reactive with tropomyosin are produced spontaneously by lamina propria B cells.
24. Shah U, Dasgupta A, Das KM: Development of ulcerative colitis-associated anti-idiotype antibody using a novel monoclonal antibody against a colonic autoantigen. Cell Immunol 1995, 166:154-157.
25. Khoo UIY, Bjarnason I, Donaghy A, Williams R, Macpherson A: Antibodies to colonic epithelial cells from the serum and colonic mucosal washings in ulcerative colitis. Gut 1995, 37:63-70.
26. Hamilton MI, Bradley NJ, Srai SK, Thrasivoulou C, Pounder RE, Wakefield AJ: Autoimmunity in ulcerative colitis: tropomyosin is not the major antigenic determinant of the Das monoclonal antibody, 7E12H12. Clin Exp Immunol 1995, 99:404-411.
27. Elson CO, Sartor RB, Tennyson GS, Riddell RH: Experimental models of inflammatory bowel disease. Gastroenterology 1995, 109:1344-1367. A comprehensive review describing animal models of IBD.
28. Ma A, Datta M, Margosian E, Horak IA: T cells, but not B cells, are required for bowel inflammation in IL-2 deficient mice. J Exp Med 1995, 182:1567-1572. The development of colitis in interleukin-2 knockout mice still occurs when these mice are bred with B cell-deficient mice.
29. Willerford DM, Chen J, Ferry JA, Davidson L, Ma A, Alt FW: Interleukin-2 receptor a regulates the size and content of the peripheral lymphoid compartment Immunity 1995, 3:521-530.
30. Neurath MF, Fuss I, Kelsall BL, Stuber E, Strober W: Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 1995, 182:1281-1290. Neutralizing antibodies to interleukin-12, an inflammatory Th1 cytokine, can downregulate colitis induced by contact allergen-induced delayed-type hypersensitivity.
31. Hollander GA, Simpson SJ, Mizoguchi E, Nichogiannopoulou A, She J, Gutierrez-Ramos JC, Bhan AK, Burakoff SJ, Wang B, Terhorst C: Severe colitis in mice with aberrant thymic selection. Immunity 1995, 3:27-38. Disruption of normal thymic maturation of T cells by genetic manipulation can result in the development of colitis.
32. Rudolph U, Finegold MJ, Rich SS, Harriman GR, Srinivasan Y, Brabet P, Bradley A, Birnbaumer L: G(i2)alpha protein deficiency: a model for inflammatory bowel disease. J Clin Immunol 1995, 15(suppl):S101-S105. In this induced mutant mouse strain, the defect may affect epithelial cell function, resulting in abnormal inflammation.
33. Hermiston ML, Gordon JI: Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 1995, 270:1203-1207. This induced mutation clearly has deleterious effects on epithelial integrity and permeability, with resultant pathologic inflammation of the mucosa.
34. Hammer RE, Richardson JA, Simmons WA, White AL, Breban M, Taurog J: High prevalence of colorectal cancer in HLA-B27 transgenic F344 rats with chronic inflammatory bowel disease. J Invest Med 1995, 43:262-268.